186 related articles for article (PubMed ID: 31538514)
1.
Manem VS; Dhawan A
Br J Radiol; 2019 Nov; 92(1103):20190198. PubMed ID: 31538514
[TBL] [Abstract][Full Text] [Related]
2. Gene Expression Signatures as Biomarkers of Tumour Hypoxia.
Harris BH; Barberis A; West CM; Buffa FM
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):547-60. PubMed ID: 26282471
[TBL] [Abstract][Full Text] [Related]
3. The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response.
Starmans MH; Zips D; Wouters BG; Baumann M; Lambin P
Radiother Oncol; 2009 Sep; 92(3):417-22. PubMed ID: 19615772
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia gene expression signatures as prognostic and predictive markers in head and neck radiotherapy.
Toustrup K; Sørensen BS; Alsner J; Overgaard J
Semin Radiat Oncol; 2012 Apr; 22(2):119-27. PubMed ID: 22385919
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of genomic predictors of radiation sensitivity using preclinical data.
Manem VSK
BMC Cancer; 2021 Aug; 21(1):937. PubMed ID: 34416855
[TBL] [Abstract][Full Text] [Related]
6. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
8. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo radiotherapy simulations of accelerated repopulation and reoxygenation for hypoxic head and neck cancer.
Harriss-Phillips WM; Bezak E; Yeoh EK
Br J Radiol; 2011 Oct; 84(1006):903-18. PubMed ID: 21933980
[TBL] [Abstract][Full Text] [Related]
10. HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).
Linge A; Lohaus F; Löck S; Nowak A; Gudziol V; Valentini C; von Neubeck C; Jütz M; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Buchholz F; Aust DE; Baretton GB; Thames HD; Dubrovska A; Alsner J; Overgaard J; Krause M; Baumann M;
Radiother Oncol; 2016 Dec; 121(3):364-373. PubMed ID: 27913065
[TBL] [Abstract][Full Text] [Related]
11. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
12. A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas.
Liu N; Boohaker RJ; Jiang C; Boohaker JR; Xu B
Oncotarget; 2015 Oct; 6(33):34649-57. PubMed ID: 26452218
[TBL] [Abstract][Full Text] [Related]
13. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
Buffa FM; Harris AL; West CM; Miller CJ
Br J Cancer; 2010 Jan; 102(2):428-35. PubMed ID: 20087356
[TBL] [Abstract][Full Text] [Related]
14. Hypoxic sensitizer and cytotoxin for head and neck cancer.
Lee DJ; Moini M; Giuliano J; Westra WH
Ann Acad Med Singap; 1996 May; 25(3):397-404. PubMed ID: 8876907
[TBL] [Abstract][Full Text] [Related]
15. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Carenzo A; Serafini MS; Roca E; Paderno A; Mattavelli D; Romani C; Saintigny P; Koljenović S; Licitra L; De Cecco L; Bossi P
Cells; 2020 Aug; 9(8):. PubMed ID: 32756466
[TBL] [Abstract][Full Text] [Related]
17. Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck.
Toustrup K; Sørensen BS; Lassen P; Wiuf C; Alsner J; Overgaard J;
Radiother Oncol; 2012 Jan; 102(1):122-9. PubMed ID: 21996521
[TBL] [Abstract][Full Text] [Related]
18. Impact of supervised gene signatures of early hypoxia on patient survival.
Seigneuric R; Starmans MH; Fung G; Krishnapuram B; Nuyten DS; van Erk A; Magagnin MG; Rouschop KM; Krishnan S; Rao RB; Evelo CT; Begg AC; Wouters BG; Lambin P
Radiother Oncol; 2007 Jun; 83(3):374-82. PubMed ID: 17532074
[TBL] [Abstract][Full Text] [Related]
19. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
[TBL] [Abstract][Full Text] [Related]
20. Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
Gong IY; Fox NS; Huang V; Boutros PC
PLoS One; 2018; 13(9):e0204123. PubMed ID: 30216362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]